Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review

Nucleos(t)ide analogues (NAs) are the main drug category used in chronic hepatitis B (CHB) treatment. Despite the fact that NAs have a favourable safety profile, undesired adverse events (AEs) may occur during the treatment of CHB. Given the eminent number of patients currently receiving NAs, even a...

Descripción completa

Detalles Bibliográficos
Autores principales: de Fraga, Raquel Scherer, Van Vaisberg, Victor, Mendes, Luiz Cláudio Alfaia, Carrilho, Flair José, Ono, Suzane Kioko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188775/
https://www.ncbi.nlm.nih.gov/pubmed/32185517
http://dx.doi.org/10.1007/s00535-020-01680-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188775/
https://www.ncbi.nlm.nih.gov/pubmed/32185517
http://dx.doi.org/10.1007/s00535-020-01680-0

Ejemplares similares